FEED
ENvue Medical, Inc.
$0.48
-0.03 (-6.47%)
At close · Jul 8
Going-concern doubt
— flagged May 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern for twelve months from the date of issuance of these interim condensed consolidated financial statements.”View the 10-Q filed May 18, 2026
Market Cap
$3.27M
Shares
6,091,840
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.48
Open$0.51
Day$0.47–0.51
52W$0.47–17.40
Avg vol 30d1.2M
Short int410K · 6.7% float · 1.0d
Short vol42%
DataJan 2020–Jul 2026
Filing10-Q · May 18
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−83%
below
Price vs 50-day avg
−47%
below
RSI (14)
26
oversold
MACD trend
Positive
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−40%
trailing
6-month return
−79%
trailing
YTD return
−79%
this year
Relative strength
−87%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
+117% holders QoQ · +10 funds added
Insider flow
Distributing
Net -$144.5K over 90 days · 100% sells
Short interest
Rising
6.73% of float · ▲ +546.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
13 holders — 13F breadth
Squeeze score
46
elevated · 0–100
Fundamentals
Revenue growth
+33%
Y/Y
Gross margin
48%
contracting
EPS growth
+81%
Y/Y
Free cash flow
$-9.4M
Balance sheet
$4.2M
net cash
Quant / Vol
risk profile
Volatility
199%
annualized · 1-yr
Max drawdown
−96%
past year
ATR
15.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 18, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−83%
Bearish
Price vs 50-day avg
−47%
Bearish
RSI (14)
26
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
+117% holders QoQ · +10 funds added
Insider flow
Distributing
Net -$144.5K over 90 days · 100% sells
Short interest
Rising
6.73% of float · ▲ +546.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
13 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $0
Now $0 · 0%
52-wk high $17
vs 200-day avg -83%
vs 50-day avg -47%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FEED
this stock
ENvue Medical, Inc.
|
$3.27M | -79.4% | +33.1% | — | 6.7% |
|
ABT
Abbott Laboratories
|
$164.43B | -23.6% | +5.7% | 26.4 | 1.3% |
|
SYK
Stryker Corp
|
$125.30B | -6.8% | +11.2% | 37.8 | 1.6% |
|
MDT
Medtronic plc
|
$104.98B | -13.9% | +8.4% | 22.0 | 1.4% |
|
BSX
Boston Scientific Corp
|
$66.60B | -53.0% | +5.5% | 18.8 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FEED | -7.4% | -39.6% | -79.4% | -7.4% | -79.4% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -7.2% | -40.5% | -86.9% | -7.2% | -88.7% |